Serum Insulin-Like Growth Factor 1 Correlates with the Risk of Nodal Metastasis in Endocrine-Positive Breast Cancer
Abstract
Share and Cite
Morgillo, F.; De Vita, F.; Antoniol, G.; Orditura, M.; Auriemma, P.P.; Diadema, M.R.; Lieto, E.; Savastano, B.; Festino, L.; Laterza, M.M.; et al. Serum Insulin-Like Growth Factor 1 Correlates with the Risk of Nodal Metastasis in Endocrine-Positive Breast Cancer. Curr. Oncol. 2013, 20, 283-288. https://doi.org/10.3747/co.20.1380
Morgillo F, De Vita F, Antoniol G, Orditura M, Auriemma PP, Diadema MR, Lieto E, Savastano B, Festino L, Laterza MM, et al. Serum Insulin-Like Growth Factor 1 Correlates with the Risk of Nodal Metastasis in Endocrine-Positive Breast Cancer. Current Oncology. 2013; 20(4):283-288. https://doi.org/10.3747/co.20.1380
Chicago/Turabian StyleMorgillo, F., F. De Vita, G. Antoniol, M. Orditura, P.P. Auriemma, M.R. Diadema, E. Lieto, B. Savastano, L. Festino, M.M. Laterza, and et al. 2013. "Serum Insulin-Like Growth Factor 1 Correlates with the Risk of Nodal Metastasis in Endocrine-Positive Breast Cancer" Current Oncology 20, no. 4: 283-288. https://doi.org/10.3747/co.20.1380